Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors

Clinical trial NCT03585465 · TERMINATED

Trial details

NCT number: NCT03585465
Sponsor: Centre Oscar Lambret
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Childhood Solid Tumor

Start date: 2019-03-26
Primary completion: 2025-05-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.